Integra LifeSciences Holdings Corporation

NASDAQ:IART

24.12 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995
Revenue 1,541.5731,557.6661,542.4481,371.8681,517.5571,472.4411,188.236992.075882.734928.305836.214830.871780.078732.068682.487654.604550.459419.297277.935229.825185.599112.62593.44264.98742.517.514.713.110.2
Cost of Revenue 653.18587.355597.808520.834564.681571.496435.511349.089326.542352.801334.085314.427299.15268.188244.918252.826214.674168.314105.53687.29970.59745.77236.01426.81621.86.15.24.73.5
Gross Profit 888.393970.311944.64851.034952.876900.945752.725642.986556.192575.504502.129516.444480.928463.88437.569401.778335.785250.983172.399142.526115.00266.85357.42838.17120.711.49.58.46.7
Gross Profit Ratio 0.5760.6230.6120.620.6280.6120.6330.6480.630.620.60.6220.6170.6340.6410.6140.610.5990.620.620.620.5940.6150.5870.4870.6510.6460.6410.657
Reseach & Development Expenses 62.687101.19393.05177.38179.57378.04163.45558.15550.89551.59652.08851.01251.45148.11444.2860.49530.65825.73211.9614.12112.8148.3047.9927.5248.78.46.46.35.2
General & Administrative Expenses 00000690.746624.096455.629415.757445.967394.25373.114358.132305.055281.102280.997225.187157.70698.27399.3659.46140.58732.36643.85422.215.820.39.60
Selling & Marketing Expenses 00000000000000000000000000000
SG&A 611.596616.316637.445594.526687.599690.746624.096455.629415.757445.967394.25373.114358.132305.055281.102280.997225.187157.70698.27399.3659.46140.58732.36643.85422.215.820.39.66.1
Other Expenses -40.03413.88216.91427.75727.0288.2881.3450.8454.588-0.763-1.801-0.72116.43312.01714.36312.87512.6528.8016.0614.2663.08-3.5532.7845.1762.21.31.821.4
Operating Expenses 714.317731.391747.41699.664794.2789.947707.921527.646476.605509.963459.035442.662426.016365.186339.745354.367268.497192.239116.294117.74775.35545.33843.14256.55433.125.528.517.912.7
Operating Income 174.076238.92197.23151.37178.977110.99844.804115.3479.58765.541-3.64473.78254.91298.69497.82447.41167.28858.74456.10524.77939.64719.18714.286-18.383-12.4-14.1-19-9.5-6
Operating Income Ratio 0.1130.1530.1280.110.1180.0750.0380.1160.090.071-0.0040.0890.070.1350.1430.0720.1220.140.2020.1080.2140.170.153-0.283-0.292-0.806-1.293-0.725-0.588
Total Other Income Expenses Net -93.007-25.02617.447-57.85-118.8738.2881.3450.8454.588-0.763-48.539-0.7210.7571.551-2.076-0.9052.971-2.01-0.7394.00921.9752.8725.6198.0094.31.821.9-19.3
Income Before Tax 81.069213.894214.67793.5260.10457.40311.38590.40660.67142.979-24.7952.02928.49482.11473.15231.00660.06248.30855.10128.00843.18922.72515.543-10.847-7.8-12.3-17-7.6-25.3
Income Before Tax Ratio 0.0530.1370.1390.0680.040.0390.010.0910.0690.046-0.030.0630.0370.1120.1070.0470.1090.1150.1980.1220.2330.2020.166-0.167-0.184-0.703-1.156-0.58-2.48
Income Tax Expense 13.32833.34445.602-40.3729.903-3.398-53.35815.84253.828.975-7.81310.8250.50516.44522.197-3.92726.59118.90117.90710.81116.328-12.552-10.8630.108-1.8-1.8-2-219.4
Net Income 67.741180.55169.075133.89250.20160.80164.74374.564-3.51934.004-16.97741.20427.98965.66950.95534.93333.47129.40737.19417.19726.86135.27726.163-11.425-6-12.3-17-7.5-25.4
Net Income Ratio 0.0440.1160.110.0980.0330.0410.0540.075-0.0040.037-0.020.050.0360.090.0750.0530.0610.070.1340.0750.1450.3130.28-0.176-0.141-0.703-1.156-0.573-2.49
EPS 0.852.1821.580.590.730.831-0.0480.52-0.30.740.521.110.880.490.610.50.620.280.460.610.54-0.33-0.18-0.38-0.58-0.27-1.21
EPS Diluted 0.842.161.981.570.580.720.820.94-0.0480.52-0.290.720.481.090.870.480.560.490.570.280.430.570.47-0.33-0.18-0.38-0.58-0.27-1.21
EBITDA 297.588276.726240.188192.858206.005143.24666.774130.07194.14177.34688.74692.80271.81138.091138.14381.46491.35682.23270.06532.36226.71525.80514.924-21.216-14.5-14.6-19.2-9.414.7
EBITDA Ratio 0.1930.1780.1560.1410.1360.0970.0560.1310.1070.0830.1060.1120.0920.1890.2020.1240.1660.1960.2520.1410.1440.2290.16-0.326-0.341-0.834-1.306-0.7181.441